Summary. The effects of naloxone and \g=b\-endorphin on LH secretion by pig pituitary cells were studied in primary cultures. On Day 4 of culture, cells (105 seeded/well) were challenged with 10\m=-\9, 10\ m=-\ 8 or 10\ m=-\ 7 m gonadotrophin-releasing hormone (GnRH), 10\m=-\10,10\m=-\9, 10\m=-\8 or 10\m=-\7 m-\g=b\-endorphin or 10\m=-\6 m-naloxone individually or in combinations. Secreted LH was measured at 4 h and 24 h after treatment and cellular content of LH was measured after 24 h. Basal LH secretion (control) was 23\m=.\5\ m=+-\7\m=.\6and 36\m=.\9 \m=+-\ 10\m=.\3 ng/well at 4h and 24 h, respectively. Relative to control at 4h, 10\m=-\9, 10\m=-\8 or 1 0 \ m = -\ 7 m-GnRH stimulated (P < 0\m=.\05) LH secretion 140%, 210% and 250%, respectively. At 24h, LH secretion was increased (P < 0\m=.\05)by GnRH compared to control, but the does\p=n-\response to GnRH was absent. Naloxone increased (P < 0\m=.\01) LH secretion 166 \ m=+-\ 13% at 4h and 141 \m=+-\ 13% (P < 0\m=.\06) at 24h. Secretion of LH after simultaneous addition of 10\ m=-\ 8 m-GnRH plus naloxone was greater (P < 0\m=.\01) than after GnRH alone at 4h but not at 24h. \g=b\-Endorphin at 10\ m=-\ 10, 10\ m=-\ 9, 1 0 \ m= -\ 8 
Introduction
Endogenous opioids may modulate luteinizing hormone (LH) secretion at the level of the central nervous system (CNS) and/or pituitary gland. Opioids may inhibit LH secretion by suppressing hypothalamic discharge of gonadotrophin-releasing hormone (GnRH; Wilkes & Yen, 1981; Blank & Roberts, 1982; Ching, 1983; Rasmussen et ai, 1989) . Pituitary responsiveness to an exogenous challenge of GnRH is unaltered in animals treated with opioid agonists or antagonists (Cicero et ai, 1980; Ferin et ai, 1984) . Moreover, some workers failed to demonstrate a direct opioid influence on pituitary LH secretion in vitro (Cicero et ai, 1979; Wiesner et ai, 1984) . However, results of several recent studies indicate a direct in-vitro effect of opioid agonists on pituitary LH secretion in rats (Cacicedo & Franco, 1986; Blank et ai, 1986) , cattle (Chao et ai, 1986 ) and sheep (Matteri & Moberg, 1985) . Direct opioid modulation of pituitary gonadotrophs therefore remains a possibility. The opioid ß-endorphin is found in the anterior pituitary gland (Smyth & Zakarian, 1980) , as well as in hypophysial portal blood of rats (Wehrenberg et ai, 1982; Sarkar & Yen, 1985) . Neurones containing ß-endorphin have been identified within the hypothalamus of the pig (Kineman et ai, 1989) and the role of opioids in modulating LH secretion has been demonstrated (Barbe/ ai, 1986 (Barbe/ ai, , 1989 [120mM-NaCl; 50mM-KCl; 5 mM-D-glucose; 1 mM-CaCl2 H20; 1-5% bovine serum albumin (BSA), Sigma] containing 3 mg collagenase Type I/ml (Sigma) and 12-5 pg DNase Type I/ml (2400 kU/mg; Sigma). Pituitaries were then incubated for 2 h at 37°C in a Dubnoff metabolic shaking bath with moderate agitation followed by centrifugation at 150 g for 10 min at room temperature. The supernatant was discarded and the cell pellet resuspended in 25 ml calcium-free Na2EDTA (2 mg/ml) digestion buffer pH 7-4containing8 pgneuraminidase/ml (Sigma) and incubated for an additional 10 min at 37°C in a Dubnoff metabolic shaker with moderate agitation. The cell suspension was then filtered through 240 pm and 20 pm nylon screens to remove undigested tissue and cell aggregates and centrifuged at 150 g for 10 min at room temperature. The supernatant was discarded and the cell pellet washed twice by resuspending in 25 ml Dulbecco's modified Eagle's medium and Ham's Nutrient Mixture F-12 (DME/F12; pH 7-4; 1 -2 g NaHC03; lOmg gentomycin; 5 mg amphotericin B/l; Sigma) and centrifuged at I50# for 10min at room temperature. Then the supernatant was discarded and the cell pellet resuspended in 5 ml culture medium [DME/F12 + 10% fetal bovine serum (FBS: Gibco, Grand Island, NY USA)] containing amphotericin and kanamycin (5 pg/ml; Sigma). Cell viability and number was determined by counting the number of cells excluding trypan blue on a haemocytometer (Tennant, 1964 Experimental protocol. At the beginning of each experiment, old medium was discarded, plates were rinsed twice with serum-free DME/F12 and pituitary cells were cultured in I ml fresh DME/F12 without serum but containing 10"9,10~8or 10 7 M-GnRH, 10"10, 10" 9, IO"8 or 10"7 M-ß-endorphin or 10~6 M-naloxone alone or in combinations. A 0-1 ml sample ofmedium was harvested at 4 h and the remaining medium harvested at 24 h after addition of treatments.
Cells were then solubilized with 0-2% Triton X-100 to recover intracellular LH. Both medium and cellular contents were assayed for LH (Kraeling el ai, 1982) . The intra-assay and inter-assay coefficients of variation were 4-8% and 90% respectively.
Statistics. Data were converted to percentage of basal secretion before averaging to minimize differences between experiments. The data were then pooled across experiments. Basal secretion or content (control) was defined as the amount of LH per 105 cells secreted into the culture medium or LH cell content in the absence of GnRH. Data were then subjected to analysis of variance using the general linear model procedures of the Statistical Analysis System (SAS, 1982) . Differences between treatment means were determined by least-squares contrasts (SAS, 1982) .
Results
Basal LH secretion was 23-5 ± 7-5 ng/well (n = 9) and 36-9 + 10-3 ng/well (n = 9) at 4 h and 24 h, respectively, while cell content for control averaged 471 + 15-5 ng/well (n = 8). Relative to control at4h, 10"9, 10~8and 10"7 M-GnRH increased (P < 005) LH secretion 140%, 210% and 250%, respectively (Fig.l) . However, at 24 h the LH dose-response to GnRH was absent but LH secretion was greater (P < 005) than for control (Fig. 1) , while cellular LH content was suppressed (P < 0003) for all doses compared to control at 24 h and averaged 70%, 49% and 77% (s.e.m. = 005%) for IO"9, 10"8 and 10~7 M-GnRH, respectively. All doses of ß-endorphin failed to alter LH secretion at 4h except for 10"9M-ß-endorphin which increased (P < 005) LH secretion to 140 ± 10% of control (Fig. 2) . Incontrasi, by 24 h of culture 10"10, 10"9and 10 "7 M-ß-endorphin inhibited LH secretion by 32 to 22% (Fig. 2) , while cellular LH content for all doses was similar to control (data not shown). Naloxone (10~6m) stimulated (P < 001) LH secretion 166 ± 13% while 10" 24 h of culture compared to GnRH alone (Fig. 3) . Although IO10 M-ß-endorphin reduced the effect of 10~9M-GnRH on LH secretion, this was not significant (Fig. 3) . ß-Endorphin in combinations with GnRH suppressed (P < 001) cellular LH content compared to GnRH alone (Fig. 4) .
Discussion
The present study demonstrates a direct effect of ß-endorphin on LH secretion from anterior pituitary cells. The specificity of this effect is indicated by antagonism of ß-endorphin inhibition of basal LH secretion by naloxone. Furthermore, increased basal and GnRH-induced LH secretion from cultured anterior pituitary cells exposed to naloxone suggests that opioids produced locally may play a role in modulating LH secretion.
The apparent similarity in LH concentrations between 4 h and 24 h may in part be due to several factors. First, when pituitary cells are continuously exposed to a secretagogue, i.e. GnRH, there is an initial release of LH, followed by a rapid decline in hormone secretion, reaching basal levels within several hours after treatment (Hopkins, 1977; Walker & Hopkins, 1978; Smith & Vale, 1981; Eddie et ai, 1982) . Secondly, basal LH secretion continues to accumulate over time (Loumaye & Catt, 1983; Chao et ai, 1986 (Chao et ai, 1986) .
The ß-endorphin-induced suppression of basal LH secretion was not apparent until 24 h after treatment. These results are consistent with those for which cultured pituitary cells of rats required 24 h exposure to ß-endorphin (Cacicedo& Franco, 1986) or morphine (Blank et ai, 1986) to inhibit basal LH secretion. In contrast, methionine-enkephalin (Met-enk) inhibited LH secretion by 2 h after treatment in cultured bovine pituitary cells (Chao et ai, 1986 ). In addition, in sheep (Matteri & Moberg, 1985) -endorphin and human ß-endorphin elevated LH secretion within 30 min of initiation of treatment. However, this effect was not demonstrable with ovine ß-endorphin or Met-enk. It should be noted that, in the study by Matteri & Moberg (1985) , cells were cultured in a perifusion system, while a static culture system was used by Cacicedo & Franco (1986) , Blank et ai (1986) and Chao et al. (1986) and in the present study. Therefore, differences in LH secretion after opioid treatment between the studies may in part be related to the type of culture system used. Such delayed effects of opioids may be related to up-regulation of opioid receptor sites by exposure to the homologous ligand, i.e. ß-endorphin, resulting in an increased sensitivity to the ligand and eventual inhibitory response (Yoburn et ai, 1988) . Moreover, Blank et ai (1986) reported that, in the rat, exposure to morphine in vitro decreased LH secretion by 3 h in enriched gonadotroph cultures and after 24 h in unfractionated pituitary cells. The authors suggested that higher sensitivity of enriched gonadotrophs to morphine may be attributable to an increased availability of opioid receptor sites on the gonadotrophs due to absence of corticotrophs which produce opioids. An alternative hypothesis would be that opioid action may be mediated by modifying the GnRH receptor. In support of this idea, the stimulatory effects of human ß-endorphin on LH secretion was suppressed by pretreatment of sheep pituitary cells in vitro with a GnRH receptor antagonist (Matteri & Moberg, 1985) . However, this seems unlikely since treatment with opioid agonists failed to influence binding of GnRH to pituitary GnRH receptors in cattle (Moss et ai, 1985) and rats (Blank et ai, 1986) .
In contrast to the delayed effect of ß-endorphin on basal LH secretion, simultaneous addition of GnRH and ß-endorphin reduced while GnRH and naloxone enhanced LH secretion by 4 h of culture. Similarly, Met-enk in cattle (Chao et ai, 1986) and human ß-endorphin in sheep (Matteri & Moberg, 1985) reduced the GnRH-induced release of LH from pituitary cells in culture but naloxone failed to enhance basal LH secretion (Matteri & Moberg, 1985) or the GnRH-induced release of LH (Chao et ai, 1986) . These results coupled with findings in the present study suggest species differences in the paracrine relationship between endogenous opioids and LH secretion at the level of the pituitary gland.
An increase in the transmembrane Ca2 + flux in pituitary gonadotrophs in response to GnRH is required for LH secretion (Huckle & Conn, 1989) . Several reports have demonstrated that opioid receptors are coupled to ion channels in neural tissue (Pepper & Henderson, 1980; Williams et ai, 1982; Werz & Macdonald, 1983) and stimulation of these receptors with opioid agonists decreased Ca2+ uptake (Ronai & Szekely, 1982 (Rossier et ai, 1977 ) and 3-5 10~9 m in the pig (Smyth & Zarkarian, 1980) . Also, portal blood concentrations of ß-endorphin may influence pituitary LH secretion, since portal blood concentrations of ß-endorphin average 3 10~10 M to 1-5 10~9m in the monkey (Wehrenberg et ai, 1982) and [2] [3] [4] [5] [6] [7] [8] 9 M in the rat (Castañas et ai, 1984) . 
